| Identification | Back Directory | [Name]
Benzenepropanamide, N-[(3S)-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-3,4-difluoro-α-(4-fluorophenyl)-β-(hydroxymethyl)-, (αS,βR)- | [CAS]
564462-36-8 | [Synonyms]
Benzenepropanamide, N-[(3S)-2,3-dihydro-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-3,4-difluoro-α-(4-fluorophenyl)-β-(hydroxymethyl)-, (αS,βR)- | [Molecular Formula]
C31H24F3N3O3 | [MOL File]
564462-36-8.mol | [Molecular Weight]
543.55 |
| Chemical Properties | Back Directory | [Boiling point ]
760.6±60.0 °C(Predicted) | [density ]
1.34±0.1 g/cm3(Predicted) | [form ]
powder | [pka]
11.74±0.70(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
γ-secretase-IN-2 (Compound 36) is an inhibitor for γ-secretase, with an IC50 of 0.07 nM[1]. | [Biological Activity]
Highly potent, cell permeable γ-secretase inhibitor (IC50= 0. 06 nM). | [storage]
+4°C | [References]
[1] Churcher I, et al., Design and synthesis of highly potent benzodiazepine gamma-secretase inhibitors: preparation of (2S,3R)-3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy-N-((3S)-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1H-benzo[e][1,4]-diazepin-3-yl)butyramide by use of an asymmetric Ireland-Claisen rearrangement. J Med Chem. 2003 Jun 5;46(12):2275-8. DOI:10.1021/jm034058a |
|
|